Ubamatamab (Anti-CA125 & CD3)

Product Specifications

CAS Number

2305629-50-7

Synonyms

REGN4018

SKU

C00927-1mg

Target

CD markers

Applications

Transmembrane Transporters

Additionnal Information

Ubamatamab is a bispecific IgG4-based antibody targeting MUC16 on tumor cells and CD3 on T cells to enhance immune activation. It is designed for the treatment of ovarian cancer by recruiting T cells for MUC16-directed tumor cell killing with reduced Fcγ receptor affinity. M.W 144.64 kDa

Storage Conditions

-80°C (avoid freeze-thaw cycles)

More Discoveries

Explore Other Products

Browse additional items from our catalog

MBS1323614 Inquire

Recombinant Buchnera aphidicola subsp. Cinara cedri 2-isopropylmalate synthase (leuA), partial

View Details

TU208070 1.0 mL

LOC100361741 3'UTR Luciferase Stable Cell Line

View Details

MBS1314251-01 0.02 mg (E-Coli)

Recombinant Rickettsia typhi UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1314251-02 0.02 mg (Yeast)

Recombinant Rickettsia typhi UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1314251-03 0.1 mg (E-Coli)

Recombinant Rickettsia typhi UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details

MBS1314251-04 0.1 mg (Yeast)

Recombinant Rickettsia typhi UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase (lpxC)

View Details